Michael Mor
Impact in
- Virology top 10%
- Poxvirus research and outbreaks
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- Tuberculosis Research and Epidemiology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
- Tuberculosis Research and Epidemiology 1
-
- T-cell and B-cell Immunology 3
- Immunotherapy and Immune Responses 2
- Co-authors
- Natalia Tarnovitski Freund (6 shared papers)Bingting Ma (2 shared papers)David Hagin (2 shared papers)Lilach Abramovitz (2 shared papers)Ye Xiang (2 shared papers)Eli Sprecher (1 shared paper)Jan Rybniker (1 shared paper)Babak Javid (1 shared paper)
- Journals
- JCI Insight (2 papers)Cell (1 paper)Virus Genes (1 paper)PLoS Pathogens (1 paper)Nature Communications (1 paper)
- Partner nations
- IsraelUnited StatesChina
In The Last Decade
Michael Mor
13 papers receiving 360 citations
Peers
Comparison fields: 5 of 46
- Virology 35
- Infectious Diseases 115
- Immunology 83
- Oncology 78
- Radiology, Nuclear Medicine and Imaging 26
Countries citing papers authored by Michael Mor
This map shows the geographic impact of Michael Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mor more than expected).
Fields of papers citing papers by Michael Mor
This network shows the impact of papers produced by Michael Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mor. The network helps show where Michael Mor may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Mor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 133 | |
| 2 | 2021 | 65 | |
| 3 | 2021 | 40 | |
| 4 | 2023 | 37 | |
| 5 | 2021 | 26 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 12 | |
| 8 | 2023 | 12 | |
| 9 | 2025 | 9 | |
| 10 | 2023 | 5 | |
| 11 | 2024 | 5 | |
| 12 | 1998 | 4 | |
| 13 | 2025 | 1 |
About Michael Mor
Michael Mor is a scholar working on Infectious Diseases, Immunology, Radiology, Nuclear Medicine and Imaging, Virology and Oncology, having authored 13 papers that have together received 363 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), T-cell and B-cell Immunology (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunotherapy and Immune Responses (2 papers), Tuberculosis Research and Epidemiology (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Virology (35 citations), Infectious Diseases (115 citations), Immunology (83 citations), Oncology (78 citations) and Radiology, Nuclear Medicine and Imaging (26 citations). Michael Mor has collaborated with scholars based in Israel, United States and China. Frequent co-authors include Natalia Tarnovitski Freund, Bingting Ma, David Hagin, Lilach Abramovitz, Ye Xiang, Eli Sprecher, Jan Rybniker, Babak Javid, Lilach Cherry and Hadas Tamir. Their work appears in journals such as JCI Insight, Cell, Virus Genes, PLoS Pathogens and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.